ABSTRACT
Cushing's disease is hypercortisolaemia secondary to an adrenocorticotrophic hormone secreting pituitary adenoma. Primary management is almost always surgical, with limited effective medical interventions available. Adjuvant therapy in the form of radiation is gaining popularity, with the bulk of the literature related to the Gamma Knife. We present the results from our own institution using the linear accelerator (LINAC) since 1990. Thirty-six patients who underwent stereotactic radiosurgery (SRS), one patient who underwent fractionated stereotactic radiotherapy (FSRT) and for the purposes of comparison, 13 patients who had undergone conventional radiotherapy prior to 1990, were included in the analysis. Serum cortisol levels improved in nine of 36 (25%) SRS patients and 24 hour urinary free cortisol levels improved in 13 of 36 patients (36.1%). Tumour volume control was excellent in the SRS group with deterioration in only one patient (3%). The patient who underwent FSRT had a highly aggressive tumour refractory to radiation.
Subject(s)
ACTH-Secreting Pituitary Adenoma/surgery , Adenoma/surgery , Pituitary ACTH Hypersecretion/surgery , Radiosurgery/methods , ACTH-Secreting Pituitary Adenoma/complications , ACTH-Secreting Pituitary Adenoma/mortality , Adenoma/complications , Adenoma/mortality , Adult , Aged , Disease-Free Survival , Female , Humans , Male , Middle Aged , Particle Accelerators , Pituitary ACTH Hypersecretion/etiology , Pituitary ACTH Hypersecretion/mortality , Treatment Outcome , Young AdultABSTRACT
INTRODUCTION: The main purpose of this study was to investigate the psychological and functional impact attributed to acoustic neuroma symptoms. MATERIALS AND METHODS: A sample of 207 acoustic neuroma patients completed a study-specific questionnaire about the severity, frequency, and psychological and functional impact of 9 acoustic neuroma symptoms. RESULTS: The survey response rate was 56.4 per cent. All symptoms had some degree of psychological impact for the majority of participants; hearing loss was the symptom most often reported to have a severe psychological impact. The majority of respondents reported functional impact attributed to hearing loss, balance disturbance, dizziness, eye problems, headache and fatigue; balance disturbance was the symptom most often reported to have a severe functional impact. For most symptoms, psychological and functional impact were related to severity and frequency. CONCLUSION: Of the acoustic neuroma symptoms investigated, hearing loss and balance disturbance were the most likely to have a severe psychological and functional impact, respectively.
Subject(s)
Neuroma, Acoustic/physiopathology , Neuroma, Acoustic/psychology , Adaptation, Psychological , Adult , Aged , Cross-Sectional Studies , Female , Hearing Loss/physiopathology , Hearing Loss/psychology , Humans , Male , Middle Aged , Postural Balance , Surveys and Questionnaires , Tinnitus/parasitology , Tinnitus/physiopathology , Young AdultABSTRACT
Primary treatment for growth-hormone secreting pituitary adenomas usually involves surgery, with treatment options for recurrent and persistent disease including repeat surgery, medication and radiation therapy. The majority of previously published series for radiation therapy in acromegaly in the past 20 years have been based on Gamma-Knife (Elekta, Stockholm, Sweden) surgery. To our knowledge, we present the largest series of linear accelerator-based treatment for this disease, with a review of 121 patients treated at our institution; since 1990, 86 patients underwent stereotactic radiosurgery (SRS), 10 patients underwent fractionated stereotactic radiotherapy (FSRT), and for the purposes of comparison we also reviewed 25 patients who underwent conventional radiotherapy prior to 1990. Tumour volume control in all three groups was excellent and consistent with previously reported literature - only three of 86 (4%) patients undergoing SRS had a documented increase in tumour size, and none of the patients undergoing FSRT had a documented increase in size following a median follow-up of 5.5 and 5.1 years for SRS and FSRT, respectively. Target growth hormone levels of <2.5 ng/mL were met by 12 of 86 (14%) of the SRS group, and by two of 10 (20%) in the FSRT group. Target insulin-like growth factor-1 levels of age and sex matched controls were achieved in 16 of 86 patients (18.6%) post-SRS and five of 10 patients (50%) post-FSRT. New hormonal deficits requiring replacement therapy were identified in 17 of 86 (19.8%) patients post-SRS which is consistent with previously published radiosurgical series. Identified non-hormonal morbidity was low (<5%).
Subject(s)
Adenoma/radiotherapy , Adenoma/surgery , Growth Hormone-Secreting Pituitary Adenoma/radiotherapy , Growth Hormone-Secreting Pituitary Adenoma/surgery , Adult , Aged , Female , Growth Hormone/blood , Humans , Insulin-Like Growth Factor I/analysis , Kaplan-Meier Estimate , Male , Middle Aged , Radiosurgery , Retrospective Studies , Young AdultABSTRACT
Non-functioning pituitary adenomas are primarily a surgically managed pathology, but recurrence or regrowth is not uncommon. Previous large series have retrospectively validated the use of the Gamma Knife (GK) as an adjuvant treatment. To our knowledge, we present the largest case series to date with the Linear Accelerator (Linac) for the management of this pathology. In this study we review the clinical course of 118 patients, 51 of whom had stereotactic radiosurgery (SRS) and 67 who had fractionated stereotactic radiotherapy (FSRT); the discriminatory feature being proximity to the optic chiasm. For comparison purposes a population of 53 patients who had conventional radiotherapy (CRT) is included. The local control rates at 5 years for SRS, FRST and CRT were 100%, 93% and 87% respectively. Treatment-related morbidity was low. These data confirm that Linac SRS and FSRT are safe and effective for the treatment of non-functioning pituitary adenomas.
Subject(s)
Adenoma/radiotherapy , Adenoma/surgery , Particle Accelerators , Pituitary Neoplasms/radiotherapy , Pituitary Neoplasms/surgery , Radiosurgery/methods , Adenoma/pathology , Adolescent , Adult , Aged , Aged, 80 and over , Child , Disease-Free Survival , Endpoint Determination , Female , Hormone Replacement Therapy , Humans , Kaplan-Meier Estimate , Male , Middle Aged , Pituitary Neoplasms/pathology , Radiosurgery/adverse effects , Survival Analysis , Treatment Outcome , Young AdultABSTRACT
The objectives of this study were to describe anxiety and depression levels among acoustic neuroma patients; examine differences in anxiety and depression across the acoustic neuroma management options of microsurgery, radiation and observation; and to investigate management, medical and demographic factors that might predict anxiety and depression in this patient group. A cross-sectional questionnaire was completed by 205 adults diagnosed with, or treated for, a unilateral acoustic neuroma within five years of questionnaire distribution. Median age of participants was 57.0 years, and 120 (58.5%) were female. Anxiety and depression were measured using the Hospital Anxiety and Depression Scale (HADS). Clinically significant anxiety was reported by 29.8% of participants and 10.2% were depressed. Mean anxiety and depression scores did not differ from general population norms. No significant differences in anxiety and depression were found across management options. Time since management, number of symptoms and comorbid medical conditions predicted anxiety, while depression was predicted by number of symptoms. This appears to be the first study among acoustic neuroma patients in which anxiety and depression were compared across management options. Treating physicians should be aware that as the number of acoustic neuroma symptoms increases, so may the likelihood of clinically significant anxiety and depression.
Subject(s)
Anxiety/epidemiology , Anxiety/therapy , Depression/epidemiology , Depression/therapy , Neuroma, Acoustic/epidemiology , Neuroma, Acoustic/therapy , Adult , Aged , Anxiety/psychology , Cross-Sectional Studies , Depression/psychology , Disease Management , Female , Humans , Male , Middle Aged , Neuroma, Acoustic/psychology , Surveys and Questionnaires , Young AdultABSTRACT
AIMS: Optic nerve sheath meningiomas typically present with unilateral visual deterioration. Here, a single centre's experience with radiotherapy aimed at local control and visual stabilisation is presented. MATERIALS AND METHODS: The meningioma database within the Radiation Oncology Department, Prince of Wales Hospital was audited for patients whose meningiomas took origin from the optic nerve sheath. Excluded from this evaluation was any patient whose meningioma secondarily involved the optic nerve. Where vision was not a consideration, treatment was given by stereotactic radiosurgery for patients with retained vision. The remaining patients were treated by fractionated radiotherapy, predominately via a stereotactic approach. The main end points were: lack of radiological progression of the tumour and maintenance of preradiotherapy vision. RESULTS: There were 15 eligible patients, one patient with neurofibromatosis had bilateral optic nerve involvement; thus, 16 optic nerves were treated. Women (10) outnumbered men (five) and the age range was 7-74 years. One patient progressed outside the volume treated (for a geographical failure) with no infield progression. This patient became blind, was re-treated by stereotactic radiosurgery, had tumour control and vision improved. Thus, for 17 optic nerves (or part thereof) treated, all patients ultimately had local control (100%) with worsening of vision only occurring in one patient. No other late morbidity was present for any patient. CONCLUSION: Optic nerve sheath meningiomas have high local control rates and preservation of vision with radiotherapy.
Subject(s)
Meningioma/radiotherapy , Optic Nerve Neoplasms/radiotherapy , Adolescent , Adult , Aged , Blindness/etiology , Child , Female , Humans , Male , Meningioma/complications , Meningioma/surgery , Middle Aged , Optic Nerve Neoplasms/complications , Optic Nerve Neoplasms/surgery , Radiosurgery , Radiotherapy Dosage , Young AdultABSTRACT
AIMS: To evaluate a single centre's experience with subglottic laryngeal carcinoma. MATERIALS AND METHODS: The laryngeal cancer database at the Prince of Wales Hospital was sourced to define a sub-population of patients presenting with primary subglottic carcinoma. Excluded from the analysis were patients having a glottic origin for their carcinoma and secondarily involving the subglottis. RESULTS: Of 969 patients with newly diagnosed laryngeal cancer, 10 (1%) had subglottic origin. T stage was six T2 and four T3, all were N0. A total laryngectomy was carried out in five patients, four of whom had postoperative radiotherapy, a hemilaryngectomy in one patient and definitive radiotherapy in four patients. There was only one local failure, who could not be salvaged, and one patient died locally controlled with metastatic disease. Thus, local control was achieved in nine of 10 patients. CONCLUSION: Although an infrequent sub-population, subglottic carcinoma has a high likelihood of being locally controlled.
Subject(s)
Carcinoma, Squamous Cell/pathology , Carcinoma, Squamous Cell/therapy , Laryngeal Neoplasms/pathology , Laryngeal Neoplasms/therapy , Aged , Aged, 80 and over , Australia , Female , Glottis/pathology , Humans , Laryngectomy , Male , Middle Aged , Neoplasm Staging , Radiotherapy, Adjuvant , Treatment OutcomeABSTRACT
Medulloblastomas - primitive neuroectodermal tumours are rare in adults. This review will evaluate a single centre's experience with this malignancy. The medulloblastoma - primitive neuroectodermal tumour database was evaluated for all patients aged more than 18 years who were referred for management. Relevant information from the database was abstracted to provide a descriptive record of this malignancy. Between 1977-2004 there were 11 patients referred, 1 with persistent disease and 10 were eligible, presenting with initial diagnosis. There was increased intracranial pressure in 50% of patients. Most patients had symptoms >3 months, with three having symptoms 1-3 months before diagnosis and one patient having thoracic dural metastases at presentation. Complete resection was recorded in four patients and six had 50-90% resection. All patients completed craniospinal radiotherapy (35-36 Gy at 1.8-2.0 Gy fractions) barring one patient, who died of surgical complications during his radiotherapy. Chemotherapy was given in five of the nine patients postradiotherapy. There were two posterior fossa recurrences, with associated supratentorial and extra central nervous system disease. Of the 10 primary patients 7 are alive with no evidence of disease, 2 died because of disease, with 1 intercurrent death. One patient developed a second malignancy. The outcome for adults matches that of the more common paediatric patients. Radiotherapy could control local disease even where complete resection was not achieved.
Subject(s)
Cerebellar Neoplasms/epidemiology , Medulloblastoma/epidemiology , Neuroectodermal Tumors, Primitive/epidemiology , Adolescent , Adult , Cerebellar Neoplasms/therapy , Databases, Factual/statistics & numerical data , Female , Follow-Up Studies , Humans , Intracranial Pressure , Male , Medulloblastoma/therapy , Neoplasm Recurrence, Local , Neuroectodermal Tumors, Primitive/therapy , Neurosurgical Procedures , New South Wales/epidemiology , Radiotherapy, Adjuvant , Rare Diseases , Retrospective Studies , Treatment OutcomeABSTRACT
BACKGROUND: Combined anterior craniofacial resection (CFR) has been in use for more than 25 years. The advent of the free revascularized tissue transfer flap in l980 permitted safe resection of tumors that had spread beyond the confines of the paranasal sinuses with immediate reconstruction of the sino-orbital cranial defect. The purpose of this study was to examine the outcomes and morbidity of a management policy of primary CFR and postoperative radiotherapy for paranasal sinus cancers infiltrating the skull base over a 21-year period. METHODS: Seventy-three patients with paranasal sinus cancers were treated at the Prince of Wales Hospital between l975 and l996. All were newly diagnosed with the exception of one patient who had received radiotherapy elsewhere 5 years earlier. Only 22% were early lesions and 31% were advanced (more than six sites involved). There were 59 men and 14 women. The mean age was 57 years. All but two patients had a performance status of either 0 or 1. Orbital exenteration was performed in 31 patients. Since l980, all major defects were reconstructed with free tissue transfer flaps. RESULTS: The 5-year cancer-specific survival (CSS) for the 73 patients was 69%, which was unchanged at 10 years. Twenty two patients died from or with their index cancer. An additional 11 patients died from unrelated causes. The actuarial overall survival (OS) at 5 and 10 years was 61% and 48%, respectively. The 5-year recurrence-free rate was 59%. The CSS for the three dominant pathologic conditions were adenocarcinoma 70%, squamous cancer 51%, and olfactory neuroblastoma 84%. The difference was not significant; however, there was a significant difference in OS, with olfactory neuroblastoma having the best prognosis. Orbital involvement, radiologic evidence of skull base erosion, and involvement of the infratemporal fossa were not poor prognostic indicators. Patients with a performance status of 0 had improved OS. There was no operative mortality. CONCLUSIONS: An aggressive policy of combined CFR and postoperative radiotherapy with free-flap reconstruction for large defects gave survival results that were comparable to less-advanced lesions and superior to many other treatment alternatives. There was a high exenteration rate (42%). Squamous cancers were associated with the greatest morbidity and poorest OS.
Subject(s)
Ethmoid Sinus/surgery , Paranasal Sinus Neoplasms/surgery , Plastic Surgery Procedures/methods , Sphenoid Sinus/surgery , Adult , Aged , Bone Transplantation/methods , Ethmoid Sinus/diagnostic imaging , Facial Bones/surgery , Female , Humans , Male , Middle Aged , Paranasal Sinus Neoplasms/diagnosis , Paranasal Sinus Neoplasms/mortality , Retrospective Studies , Skin Transplantation/methods , Skull/surgery , Sphenoid Sinus/diagnostic imaging , Survival Rate , Tomography, X-Ray Computed , Treatment OutcomeABSTRACT
PURPOSE: The poor prognosis of elderly patients in many cancers may be due to less thorough investigation and less aggressive treatment because of the perception that radical treatment will be poorly tolerated and that elderly patients have a limited life expectancy. We wished to assess whether older age is associated with (a) less radical treatment, (b) poorer outcome, or (c) greater toxicity, after adjusting for other possible contributing factors. METHODS AND MATERIALS: A retrospective study of patients with loco-regional oropharyngeal cancer treated between January 1980 and December 1985 was conducted. Patients were treated with radiotherapy, surgery, chemotherapy, or combinations. Cox regression was used to assess age effects while allowing for the influence of other factors. RESULTS: Eighty-eight patients were treated radically and 16 palliatively. Treatment intent (radical or palliative) did not appear to be related to age, before (p = 0.42) or after adjusting for other factors (p = 0.34). In a selected group of 86 radically treated patients ages ranged from 33 to 85 (median 60). There were 35 loco-regional failures and 58 deaths (38 related to oropharyngeal cancer). Older patients were prescribed and received lower doses of radiation. However, older age was not related to the risk of loco-regional recurrence (p = 0.96) or shorter survival (p = 0.67), and was not associated with duration of treatment interruption or severity of toxicity after adjustment for prognostic factors. There was some suggestion of a higher risk of recurrence with increasing age for patients under 70 years but with a risk for patients over 70 at least equal to that of the youngest group. Elderly patients in our study may have been a selected group. CONCLUSION: Older patients with loco-regional oropharyngeal cancer, or at least a subset of them, appear to be able to tolerate radical courses of radiotherapy, and to have similar outcomes as do younger patients.
Subject(s)
Oropharyngeal Neoplasms/radiotherapy , Adult , Age Factors , Aged , Aged, 80 and over , Combined Modality Therapy , Female , Humans , Male , Middle Aged , Neoplasm Staging , Oropharyngeal Neoplasms/mortality , Oropharyngeal Neoplasms/pathology , Oropharyngeal Neoplasms/therapy , Retrospective Studies , Survival Analysis , Treatment Failure , Treatment OutcomeABSTRACT
PURPOSE: To retrospectively assess a protocol of split-course accelerated radiation therapy (SCAT) for selected head and neck cancers. METHODS AND MATERIALS: SCAT consisted of 1.8 Gy per fraction administered twice daily with a minimum gap between fractions of 6 h. The treatment protocol prescribed an initial 16 fractions followed by a planned 5 to 12 day break, and then a further 20 to 22 fractions for a total dose ranging from 64.8 to 72 Gy delivered in 5 to 6 weeks. RESULTS: Twenty-eight patients received SCAT for histologically confirmed head and neck cancer between January 1987 and August 1991. All patients were followed up until December 1, 1993. The mean potential follow-up time was 4.2 years (range: 2.9-6.2 years). All patients completed the treatment protocol. Thirteen tumors were laryngeal in origin, eight hypopharyngeal, four paranasal sinus, and three oropharyngeal. There were no Stage I, three Stage II, nine Stage III, and 12 Stage IV tumors. Four tumors were not staged (two paranasal sinus cancers and two surgical recurrences). Early and late toxicities were moderate to severe. Confluent mucositis was experienced by 27 of the 28 patients (96%). One patient required a prolonged midtreatment break of 24 days. Nine patients (32%) required narcotic analgesia for pain relief. Eleven patients (39%) required hospitalization for nasogastric feeding or pain control. The median length of hospital stay was 14 days (range 7-98 days). The actuarial rate of severe late toxicity at 3 years was 47% (standard error (SE) = 13%). A complete tumor response was achieved in 86% of patients. The actuarial local control rate at 3 years was 43% (SE = 11%) and the actuarial survival rate at 3 years was 25% (SE = 8%). CONCLUSION: Given the encouraging complete response rate and local control for such advanced tumors, SCAT for locoregionally advanced tumors merits further investigation. However, because of the significant late toxicity observed, the total dose, interfraction interval, and fractionation technique used should be reconsidered.
Subject(s)
Carcinoma, Squamous Cell/radiotherapy , Head and Neck Neoplasms/radiotherapy , Stomatitis/etiology , Actuarial Analysis , Adult , Aged , Carcinoma, Squamous Cell/mortality , Carcinoma, Squamous Cell/pathology , Female , Follow-Up Studies , Head and Neck Neoplasms/mortality , Head and Neck Neoplasms/pathology , Humans , Male , Middle Aged , Neoplasm Staging , Radiotherapy Dosage , Retrospective StudiesABSTRACT
A man aged 26 years had been subject to frequent transient episodes of left homonymous hemianopia, initially accompanied by visual hallucinations and left miosis, since the age of 8 years. These partial seizures recurred 3 to 30 times each month in spite of treatment with anticonvulsant medication. The causative lesion, which had escaped detection by cerebral angiography and repeated computed tomographic scanning, was shown by magnetic resonance imaging to be a small cavernous hemangioma in the right occipital lobe. This was treated by a course of fine-beam radiotherapy directed to the lesion. After treatment the partial attacks ceased, although one nocturnal clonic seizure occurred 12 months after radiotherapy and 6 weeks after stopping all anticonvulsant medication.